|
Volume 271, Number 43,
Issue of October 25, 1996
pp. 26637-26645
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Molecular Cloning, Overexpression in Escherichia
coli, Structural and Functional Characterization of House Fly
Cytochrome b5*
(Received for publication, June 11, 1996, and in revised form, July 16, 1996)
Victor M.
Guzov
,
Heather L.
Houston
§,
Marat B.
Murataliev
,
F. Ann
Walker
§ and
René
Feyereisen
¶
From the Departments of Entomology and
§ Chemistry, University of Arizona, Tucson, Arizona
85721
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
A microsomal cytochrome
b5 cDNA from the house fly, Musca
domestica, was cloned and sequenced. The deduced amino acid
sequence of the full-length house fly cytochrome
b5 (134 residues) is 48% identical to that of
rat microsomal cytochrome b5. The house fly
cytochrome b5 protein was overexpressed in
Escherichia coli, purified, and characterized. Absorption
and EPR spectroscopy reveal properties very similar to cytochromes
b5 from vertebrates. NMR spectra indicate that
the orientation of the heme in the protein relative to its ,
meso axis is about 1:1. A redox potential of 26 mV
versus standard hydrogen electrode was measured by cyclic
voltammetry on a modified gold electrode in the presence of
hexamminechromium(III) chloride. The cytochrome
b5 is reduced by house fly cytochrome P450
reductase in a reconstituted system at a high rate (5.5 s 1), and it stimulates heptachlor epoxidation when
reconstituted with house fly cytochrome P450 reductase, cytochrome P450
6A1, phospholipid, and detergent. Cytochrome b5
decreases the apparent Km for P450 reductase and
increases the Vmax for heptachlor epoxidation
at constant cytochrome P450 6A1 concentrations. The results indicate
that cytochrome b5 stimulates a step following
the first electron transfer during cytochrome P450 6A1 turnover.
INTRODUCTION
Cyt b51 was
first discovered in Cecropia silkworm larvae (1), but the
functions of this membrane-bound heme protein have been most
extensively studied in mammals (2, 3). A microsomal form of cyt
b5 is required for numerous biosynthetic and
biotransformation reactions, which include P450-dependent
reactions (3), desaturation of fatty acids (4), plasmalogen
biosynthesis (5), and cholesterol biosynthesis (6, 7). A soluble form
of cyt b5 is involved in the reduction of
methemoglobin in erythrocytes (8) and the biosynthesis of
N-glyconeuraminic acid (9). A mitochondrial form, bound to
the outer mitochondrial membrane, has been described in mammals as well
(10). Cyt b5-like sequences are also found as
part of larger polypeptides such as flavocytochrome
b2, sulfite oxidase and nitrate reductase (11),
probably as a result of gene fusion events. The role of cyt
b5 in microsomal P450-dependent
monooxygenase reactions has been studied most extensively.
P450s are a large superfamily of heme proteins which play a crucial
role in the biosynthesis of a number of endogenous compounds (steroid
hormones, vitamins D3, eicosanoids, and so forth) and in
the activation or detoxification of a vast variety of xenobiotics. In
many of these reactions, cyt b5 is known to
determine the fate of certain substrates by either stimulating (2, 3)
or inhibiting (2, 12, 13) substrate metabolism, or even by influencing
the type of reaction catalyzed (14). The stimulating effect of cyt
b5 has been thought to result from: 1) enhanced
rate of the second electron transfer to P450 (12, 15, 16); 2) increased
``coupling'' of the reaction, i.e. inhibition of
superoxide or hydrogen peroxide formation (2, 12, 17, 18); 3)
allosteric effects (19, 20); and 4) stimulation of the first electron
transfer from P450 reductase to some P450s (21). However, the exact
mechanism by which cyt b5 affects
P450-dependent reactions remains unclear.
Insect P450s have been extensively studied because of their crucial
role in the biosynthesis of hormones regulating insect growth,
development, and reproduction (ecdysteroids and juvenile hormones) and
in the biotransformation of foreign compounds of synthetic
(insecticides) or natural (plant and microbial toxins) origin (22).
Metabolism of insecticides by P450s is a major mechanism of insecticide
resistance in insects (22, 23), and detoxification of plant toxins by
P450s is thought to be an adaptation to the hazards of herbivory (24).
Both CYP6A1, an insect P450, which is overproduced in
insecticide-resistant strains of the house fly, and
NADPH-dependent cytochrome P450 reductase, which provides
electrons to P450s from NADPH, have been cloned from the house fly,
Musca domestica (25, 26) and expressed in E. coli
(27). We have found that epoxidation of the cyclodiene insecticide
heptachlor by CYP6A1 is stimulated by rat microsomal cyt
b5 in a reconstituted
system.2 Furthermore, immunological
evidence for the involvement of cyt b5 in
several P450-dependent monooxygenase activities in house
fly microsomes has been reported (28).
Our concerted effort to clone, express, and reconstitute elements of
the insect cytochrome P450 system therefore led us to clone house fly
cyt b5 cDNA. In addition to a better
understanding of the role of cyt b5 in
P450-mediated reactions, it was felt that the characterization of house
fly cyt b5 would facilitate the study of the
evolutionary conservation of structural and functional
properties of this electron carrier. We report here that the cloned
house fly cyt b5 has been overexpressed in
E. coli, purified to electrophoretic homogeneity, and
extensively characterized both structurally by a number of
spectroscopic techniques (absorption, NMR, EPR) and functionally (redox
and electron-transfer properties). We reconstituted in vitro
an insect P450 system consisting of P450 reductase, CYP6A1, cyt
b5, and phospholipid. CYP6A1-catalyzed
epoxidation of the insecticide heptachlor is stimulated by cyt
b5 in this system. The mechanisms by which cyt
b5 stimulates P450 turnover are discussed.
EXPERIMENTAL PROCEDURES
Amplification of a Partial cDNA Encoding House Fly Cytochrome
b5 by RT-PCR
Four-day-old larvae of the
diazinon-resistant strain ``Rutgers'' of the house fly, M. domestica, were used as the source of poly(A)+ RNA.
About 1 µg of poly(A)+ RNA was reverse transcribed using
the Superscript RNase H- Reverse Transcriptase Kit (Life Technologies,
Inc.) and an 18-mer oligo(dT) primer. The mRNA-cDNA duplex was
used as template for PCR with AmpliTaq polymerase (Perkin Elmer) and a
pair of degenerate oligonucleotide primers for the two heme-binding
regions of known cyt b5s. The forward primer
(for KFLEEHPG) was 5 -AA(A/G) TT(C/T) (C/T)TI GA(A/T) GA(A/T) CA(C/T)
CCI GG(A/T/C) GG-3 . The reverse primer (for ATENFEDVG) was 5 -CCI
A(C/T)(A/G) TC(C/T) TC(A/G) AA(A/G) T(C/T)I TCI GT(A/T/G) GC. Upon
reamplification, DNA from a faint band of the expected size (86 base
pairs) was purified using the Sephaglas BandPrep Kit (Pharmacia Biotech
Inc.), cloned into the pCR II plasmid (Invitrogen) and sequenced with
the Sequenase Version 2.0 DNA sequencing kit (U. S. Biochemical
Corp.).
Isolation of the House Fly Cyt b5 cDNA
A
house fly cDNA library in ZAP (25) (approximately 1 × 106 plaques) was screened at high stringency with the
partial house fly cyt b5 cDNA obtained by
RT-PCR. The 32P-labeled probe was generated using Prime-It
II kit (Stratagene) modified by replacing random primers with the
degenerate primers used for RT-PCR (see above). Inserts were excised
from purified phage, recircularized into pBluescript plasmids, and
sequenced. Nucleotide sequences were analyzed with the BLAST program on
the NCBI Blast Server (29).
Construction of the Vector for Expression of the House Fly Cyt
b5 in E. coli
Plasmid pCWori+ (kindly
provided by Dr. F. W. Dahlquist, University of Oregon, Eugene, OR) was
used for the expression of the house fly cyt b5.
This plasmid contains an NdeI site adjacent to the ATG
codon. An NdeI site was inserted at the 5 -end of the cyt
b5 coding region using PCR mutagenesis. An
alanine codon (GCT) was inserted at position 2 because it is a
preferred second codon for expression of the lacZ gene (30),
and two silent changes at the 5 -end of the cDNA were introduced to
reduce the probability of secondary structure formation in the
mRNA. The complete coding region of the house fly cyt
b5 cDNA was amplified in the process of PCR
mutagenesis. The forward primer was 5 -CAT ATG GCT TCT TCT GAA GAC GTT
AAA TAC TTT ACC-3 . The reverse primer was 5 -AAG CTT TGT GTC TCT CTA
TGC-3 . This primer corresponds to a short sequence just 3 of the stop
codon and introduces a HindIII site for further cloning. The
PCR product was cloned into the pCR II vector and sequenced. The
NdeI/HindIII-digested TA-clone containing the PCR
product was then ligated with
NdeI/HindIII-digested pCWori+ vector
to give the expression plasmid pCb5 which was used to transform the
E. coli strain BL21 for expression experiments.
Expression in E. coli and Purification of the House Fly Cyt
b5
An overnight culture of E. coli strain
BL21 (pCb5) in Terrific Broth (31) modified with a mixture of trace
elements (32) and containing 200 µg/ml ampicillin was diluted
100-fold into the same medium. The flasks were shaken at 125 rpm and
37 °C until the A600 of the culture was
1.0-1.5. Isopropyl- -D-thiogalactopyranoside was then
added to a concentration of 0.1 mM, and the flasks were
shaken at 125 rpm and 30 °C for 40-48 h. The cells were pelleted,
washed with 10 mM sodium phosphate, pH 7.4, containing 0.15 M NaCl, resuspended in 75 mM Tris-HCl, pH 8.0, containing 0.1 mM EDTA, and stored frozen at 80 °C
overnight. After thawing, phenylmethylsulfonyl fluoride was added to a
concentration of 2 mM, and the cells were sonicated on ice.
The suspension was centrifuged at 100,000× g for 1 h,
and the pellet was resuspended in 20 mM Tris, pH 8.0, containing 10% glycerol and 0.5 mM EDTA (buffer A) to give
a protein concentration of 3 mg/ml. CHAPS was then added to a
concentration of 1% (w/v), and the suspension was stirred for 1 h
on ice. The suspension was centrifuged at 100,000 × g
for 1 h, and the resulting supernatant was loaded onto a
DEAE-Sepharose column equilibrated with buffer A containing 0.5%
sodium cholate (buffer B). The column was washed with buffer B with
0.2% Emulgen 911, then with buffer B, and the protein was eluted with
0.1 M NaCl in buffer B. The red-colored fractions were
combined, diluted 10-fold with 0.1 M sodium phosphate, pH
7.4, 10% glycerol, 0.5 mM EDTA (buffer C) and loaded onto
a phenyl-Sepharose column equilibrated with buffer C. The column was
washed with 10 mM sodium phosphate, pH 7.4, 10% glycerol,
0.5 mM EDTA (buffer D). A linear gradient of buffer D and
buffer D containing 0.5% sodium cholate and 0.1% Emulgen 911 was then
applied. The red-colored fractions were combined and applied onto a
DEAE-Sepharose column equilibrated with buffer A. The column was washed
with buffer A with 0.1% Emulgen 911, then with buffer B (no Emulgen
911) containing increasing concentrations of NaCl and eluted with
buffer B with 0.3 M NaCl. The protein was concentrated
through a PM10 membrane (Amicon) replacing the buffer with 10 mM sodium phosphate, 10% glycerol, 0.5 mM
EDTA.
Purification of Recombinant House Fly CYP6A1 and P450
Reductase
The membrane fractions from E. coli cells
expressing CYP6A1 or P450 reductase were obtained and solubilized as
described previously (27). CYP6A1 was further purified by a combination
of DEAE-Sepharose and octyl-Sepharose column chromatography to apparent
electrophoretic homogeneity. P450 reductase was purified using
phenyl-Sepharose chromatography followed by affinity chromatography on
2 ,5 -ADP-agarose (33). Detergents were removed on a DEAE-Sepharose
column.
EPR and 1H NMR
The EPR spectrum was acquired
using an ESP 300 E Bruker spectrometer operating at 9.38 GHz with 200 microwatts of microwave power. The modulation frequency was 100 kHz,
and the modulation amplitude was 10 G. The spectrum was acquired at 4.2 K using the model ESR 900 Oxford Instrument Cryostat. 1H
NMR spectra were recorded at 25 °C on a Varian Unity 300 spectrometer operating in the quadrature mode with a proton frequency
of 299.997 MHz. Recombinant house fly cyt b5
solutions (1 mM) were obtained by repeated exchanges of a
concentrated aqueous solution of the protein with 30 mM
phosphate buffer in D2O at pH* = 7.0. The pH* values were
not corrected for the isotope effect. One-dimensional 1H
NMR spectra were obtained using a spectral bandwidth of 15 kHz using a
30° pulse width with presaturation of the residual HOD water peak
during a 500-ms relaxation delay between transients; 1000-6000
transients were collected. The time-domain data were treated with an
exponential multiplication function with a line broadening of 10 Hz
before Fourier transformation. Spectra were referenced to the residual
HOD water peak, = 4.84 ppm.
Cyclic Voltammetric Measurements
Linear staircase cyclic
voltammetry was carried out using a BAS electrochemical system
utilizing a gold disk working electrode, platinum gauze counter
electrode, and silver-silver chloride miniature reference electrode as
described previously (34). Before each experiment the working electrode
was cleaned and surface modified with -mercaptopropionic acid for 10 min (34). The cyt b5 solutions used for these
cyclic voltammetry studies were typically 100 µM in cyt
b5. Hexamminechromium(III) chloride (0.75 mM) was used as charge mediator. Phosphate buffer (30 mM, pH 7.0) was used as the electrolyte.
CYP6A1 Activity Assay
The CYP6A1 activity was assayed in a
0.1 M potassium phosphate buffer, pH 7.6, at 25 °C in a
final volume of 100 µl. The reaction mixture contained 50 µM heptachlor as a substrate, NADPH-regenerating system
(100 µM NADPH, 2.0 mM glucose 6-phosphate,
4.0 units/ml glucose-6-phosphate dehydrogenase) and final
concentrations of CYP6A1, P450 reductase, and cyt
b5 as given in the legends to Figs. 9, 10, 11. Prior
to assay, CYP6A1 was incubated for 15 min on ice with P450 reductase
and, where indicated, cyt b5 in the presence of
1 mg/ml
L- -dilauroyl-sn-glycero-3-phosphocholine and
0.2% CHAPS in a 0.1 M potassium phosphate buffer, pH 7.6 (enzyme mixture). The reaction was started by the addition of 10 µl
of the enzyme mixture to 90 µl of the reaction mixture, and after
3-5 min the incubation was stopped by the addition of 20 µl of 5 N HCl. After extraction with 0.5 ml of iso-octane, the
organic phase was dried over anhydrous sodium sulfate, and 2-µl
aliquots were analyzed by gas chromatography with electron capture
detection (27).
Fig. 9.
Kinetics of cyt b5
(A) and CYP6A1 (B) reduction by P450 reductase
in reconstituted system. A, cyt b5
reduction. Syringe 1 contained 1.0 µM P450 reductase and
1.0 µM cyt b5 reconstituted as
described under ``Experimental Procedures.'' Syringe 2 contained 100 µM NADPH, 2 mM glucose 6-phosphate, and 0.2 unit/ml glucose-6-phosphate dehydrogenase. Equal volumes of the two
solutions were mixed, and the absorbance increase at 423 nm was
recorded. B, CYP6A1 reduction. The solutions were prepared
in the buffer saturated with CO. Syringe 1 contained 0.54 µM P450 reductase and 0.56 µM CYP6A1
reconstituted as described under ``Experimental Procedures'' and 50 µM heptachlor. Syringe 2 contained 100 µM
NADPH, 50 µM heptachlor, 2 mM glucose
6-phosphate, and 0.2 unit/ml glucose-6-phosphate dehydrogenase. Equal
volumes of the two solutions were mixed and the absorbance increase at
448 nm was recorded. Lines on the curves represent a first-order
reaction fit with rate constants of 5.5 s 1 (A)
and 3.0 s 1 (B), respectively. The
insets show the end point difference spectra of the cyt
b5 and CYP6A1 reduction by P450 reductase
(solid line) and by sodium dithionite (dotted
line).
[View Larger Version of this Image (26K GIF file)]
Fig. 10.
Effect of cyt b5
concentration on the rate of heptachlor epoxidation by CYP6A1.
Proteins were reconstituted as described under ``Experimental
Procedures.'' The final concentration of CYP6A1 in the reaction
mixture was 0.05 µM, the final concentrations of P450
reductase was 0.03 µM (open circles) or 1.0 µM (closed circles), and the final
concentrations of cyt b5 are shown on the plot.
Inset, the data presented as a ratio of the activity with
cyt b5 to the activity without cyt
b5.
[View Larger Version of this Image (24K GIF file)]
Fig. 11.
Effect of P450 reductase concentration of
the rate of heptachlor epoxidation by CYP6A1 in the absence (open
circles) or presence (closed circles) of 1.0 µM cyt b5. The final
concentration of CYP6A1 in the reaction mixture was 0.05 µM and P450 reductase was as shown on the plot.
A, direct plot; B, double reciprocal plot of the
data in A. The intersections give the values of
Km and Vmax of 0.5 µM and 24 min 1 in the absence and 0.14 µM and 57 min 1 in the presence of cyt
b5, respectively.
[View Larger Version of this Image (16K GIF file)]
Stopped-flow Spectrophotometry
The enzyme mixtures were
prepared essentially as described for the CYP6A1 activity assay and,
after 15 min incubation on ice, were diluted to a 1.6-2.0-ml volume
with 0.1 M potassium phosphate buffer, pH 7.6, and placed
in the first syringe. The concentrations of the proteins used are given
in the legends to the figures. A second syringe contained 100 µM NADPH, 2.0 mM glucose 6-phosphate, and 0.2 unit/ml glucose-6-phosphate dehydrogenase in the same buffer. When
CYP6A1 reduction was measured, the reaction mixture also contained 50 µM heptachlor, and the buffer was saturated with carbon
monoxide by a 30-min bubbling of CO gas. No special measures were taken
to remove oxygen from the solutions in order to keep the conditions as
close as possible to the conditions of the CYP6A1 activity assay.
Other Procedures
Concentrations of cyt
b5 and P450 were determined by difference
spectrophotometry (35). Recombinant house fly cyt
b5 is present in a reduced form in whole
E. coli cells. Therefore, sodium dithionite and hydrogen
peroxide were added to the sample and reference cuvettes, respectively,
to determine cyt b5 by reduced versus
oxidized difference spectra. Molar concentration of recombinant house
fly P450 reductase was calculated based on protein content (36).
RESULTS
Molecular Cloning and Expression in E. coli
Cloning of House Fly Cyt b5
Conserved sequences
around the two His ligands of the heme in known cyt
b5s (Fig. 1) were used to design
two oligonucleotide primers for RT-PCR from larval mRNA of the
house fly. Cloning of the PCR products and sequencing of a few
individual clones revealed the presence of two clones (1-2 and 1-7)
containing cyt b5-like sequences (EETLDEVAGRD
and EEVLIEQAGKD, respectively). These short PCR products were 53%
identical at the nucleotide level.
Fig. 1.
Alignment of selected cyt
b5 amino acid sequences. Numbering on top
is according to the crystal structure of the bovine cyt
b5 (37). indicates residues that interact
with the heme in isomer B of microsomal cyt b5
(37, 38). indicates residues of the ``b5
fold'' described by F. S. Mathews (11). Conserved residues are in
bold. Rat OMM represents rat outer mitochondrial membrane
protein. His-39 and His-63 are the axial ligands of the heme.
[View Larger Version of this Image (81K GIF file)]
The inserts of clones 1-2 and 1-7 were used as probes to screen a house
fly ZAP cDNA library, and six identical cDNA clones with
inserts of approximately 1.35 kilobase pairs were isolated. One of
these, clone 16-A2 was shown to contain an open reading frame of 402 base pairs encoding a protein of 134 amino acids (15.4 kDa) at the
5 -end of the cDNA. The 5 -end of clone 16-A2 containing the open
reading frame was deposited in GenBankTM under the
accession number L38464[GenBank] (706 base pairs). Clone 16-A2 contained the
exact sequence of the initial RT-PCR clone 1-7. No cDNA clone
corresponding to the initial RT-PCR clone 1-2 was found.
Comparison of the coding region of the cDNA revealed a high
similarity to known cyt b5s. The deduced protein
sequence was 48% identical to rat microsomal cyt
b5 and 46.5% identical to rat outer
mitochondrial membrane cyt b5. It was only 27%
identical to a portion of a Drosophila virilis sequence
deposited in GenBankTM as a cyt b5
(39). A phylogenetic tree based on an alignment of amino acid sequences
of known cyt b5s and cyt
b5-like proteins reveals that the putative house
fly cyt b5 clusters with all known cyt
b5s and clearly differs from cyt
b5-like proteins and the D. virilis
cyt b-like protein (Fig. 2).
Fig. 2.
Phylogenetic tree of representative cyt
b5s and cyt b5-like
sequences. b5s are microsomal cyt
b5 sequences from various species. Rat OMM
b5 is the outer mitochondrial membrane cyt
b5. Flavocyt b2 is the
cyt b5-like domain of yeast flavocytochrome
b2. b5-like Drosophila is
the N-terminal domain of a D. virilis sequence reported as
cyt b5 (39).
[View Larger Version of this Image (16K GIF file)]
Expression in E. coli and Purification of House Fly Cyt
b5
A plasmid for expression in E. coli
(Fig. 3) was constructed as described under
``Experimental Procedures.'' We obtained expression levels of 9 µmol/L culture in small scale cultures (50 ml) and 4-4.5 µmol/L
culture in large scale cultures (500-750 ml). House fly cyt
b5 was found in E. coli in the
reduced Fe(II) form as was reported for rat and human cyt
b5s expressed in E. coli (40), and
the protein gradually oxidized during purification. Table
I shows purification steps of the recombinant house fly
cyt b5. After cell lysis by sonication, most of
the cyt b5 was found in the membrane fraction
(Table I). CHAPS treatment solubilized about 65% of the
cyt b5. The solubilized protein was purified by
a combination of ion-exchange and hydrophobic interaction
chromatography to apparent electrophoretic homogeneity (Fig.
4) with a yield of 23% (Table I). The protein mobility
under the conditions of SDS-PAGE corresponded to a polypeptide of about
19 kDa.
Fig. 3.
Preparation of the house fly cyt
b5 cDNA for expression in E. coli. A, primers used to mutate the cDNA by PCR.
Mutant bases and amino acids are in bold and
underlined. B, construction of the expression plasmid.
[View Larger Version of this Image (22K GIF file)]
Fig. 4.
SDS-electrophoresis in 15% polyacrylamide
gel. 1, lysate of BL21 (pCWori+); 2,
lysate of BL21 (pCb5); 3, purified cyt
b5.
[View Larger Version of this Image (47K GIF file)]
Spectral Characterization of Recombinant House Fly Cyt
b5
Absorption Spectroscopy
The absorbance spectra of oxidized
and reduced recombinant house fly cyt b5 (Fig.
5) show a wavelength maximum at 413 nm in the oxidized
form and at 423, 526, and 556 nm in the reduced form. These
characteristics are typical of cyt b5s
(40, 41, 42, 43).
Fig. 5.
Absorbance spectra of purified recombinant
house fly cyt b5. Solid line,
oxidized form; dashed line, sodium dithionite-reduced
form.
[View Larger Version of this Image (22K GIF file)]
EPR and 1H NMR Studies
The EPR spectrum of the
recombinant cyt b5 from house fly is shown in
Fig. 6. The rhombic signal with three resolved g values
(g1 = 3.07, g2 = 3.22, and g3 = 1.35) is very similar to those of other cyt b5s,
including bovine microsomal (44), bovine erythrocyte (45), recombinant
rat microsomal (46), and recombinant rat outer mitochondrial membrane
(43) cyt b5s. The NMR spectrum of the
recombinant house fly ferricytochrome b5 is
shown in Fig. 7, where the conditions of spectral
acquisition were optimized for observing the hyperfine-shifted heme
resonances rather than the protein resonances. From the number of
resonances observed and their positions as compared to the NMR spectra
of other cyt b5s (38, 43, 47, 48) summarized in
Table II, it is clear that two forms, A and B, of the
protein are present in approximately equal amounts. These forms result
from the two possible ways that the noncovalently attached heme
molecule can be found in the protein, which differ by a 180° rotation
about the , meso axis of the heme (38, 49, 50, 51). Thus,
based on the results of absorption, EPR, and NMR spectroscopy we
conclude that the gene cloned in this study encodes a typical cyt
b5.
Fig. 6.
X-band EPR spectrum of recombinant
house fly ferricytochrome b5 recorded at 4.3 K. The three g values are shown. The X marks an
impurity signal arising from CuO in the cryostat.
[View Larger Version of this Image (15K GIF file)]
Fig. 7.
Proton NMR spectrum of a 1 mM
solution of recombinant house fly ferricytochrome
b5 recorded at 300 MHz in D2O.
The spectrum was recorded and plotted in such a way as to emphasize the
resonances of the heme. These heme resonances are shifted outside of
the normal diamagnetic window (~0-10 ppm) due to the unpaired
electron on the iron(III) center. The three peaks at 30.8, 23.1, and
20.0 ppm are heme methyl resonances and the peaks at 14.9 and 14.8 ppm
may also be due to heme methyls.
[View Larger Version of this Image (24K GIF file)]
Table II.
Proton NMR shifts of the heme methyl resonances and A:B ratios of
various cyt b5s
| Heme methyl |
Chemical shift
|
| Chicken
microsomala |
Bovine microsomala |
Recombinant
bovine microsomalb |
Recombinant human
erythrocytec |
Recombinant rat
microsomala |
Recombinant rat outer
mitochondriald |
Recombinant house fly microsomale
|
|
|
ppm
|
| B3-Me |
29.9 |
31.0 |
~31.0 |
31.5 |
31.8 |
31.0 |
30.9
|
| B8-Me |
27.5 |
27.5 |
~27.5 |
~27f |
24.3 |
25.9 |
23.1
|
| A5-Me |
23.5 |
21.8 |
~22.3 |
21.6 |
20.4 |
22.5 |
20.0
|
| A3-Me |
13.2 |
14.4 |
~14.5 |
~14f |
14.4 |
14.7 |
14.9g
|
| A1-Me |
12.6 |
11.5 |
~12.8 |
~11f |
10.7 |
13.2 |
14.8g
|
| A:B
ratio |
20:1 |
9:1 |
~9:1 |
9:1 |
1.5:1 |
1:1 |
~1:1 |
|
|
a
Data taken from Lee et al. (38).
|
|
b
Approximate values taken from Burch et al. (47).
|
|
c
Data taken from Lloyd et al. (48).
|
|
d
Data taken from Rivera et al. (43).
|
|
e
This work. Assignments are based on comparison with NMR
spectra of other cyt b5s (38, 43, 47, 48).
|
|
f
Approximate values taken from Lloyd et al. (48).
|
|
g
Assignments not yet confirmed.
|
|
Functional Characterization of Recombinant House Fly Cyt
b5
In order to investigate the role of house fly cyt
b5 in insect cytochrome
P450-dependent monooxygenase systems we have characterized
the electron-transfer properties of the protein, i.e. redox
potential and reduction by NADPH-dependent cytochrome P450
reductase. We have also studied the effect of house fly cyt
b5 on epoxidation of the cyclodiene insecticide
heptachlor catalyzed by CYP6A1 in a reconstituted system.
Redox Properties of Recombinant House Fly Cyt
b5
Fig. 8 shows the cyclic
voltammogram of the recombinant house fly cyt b5
obtained on a gold electrode modified with -mercaptopropionate and
in the presence of 0.75 mM hexamminechromium(III) chloride.
The peak separation, Ep = 65 mV (Fig. 8), is very
similar to that observed for recombinant rat outer mitochondrial
membrane and bovine microsomal cyt b5s under the
same conditions (34). The calculated midpoint potential of house fly
cyt b5 is 26 mV versus SHE,
approximately 26 mV more negative than that of bovine microsomal cyt
b5 and 44 mV more positive than that of rat
outer mitochondrial cyt b5 measured under the
same experimental conditions (34).
Fig. 8.
Cyclic voltammogram of 100 µM
recombinant house fly cyt b5 obtained on a gold
electrode modified with -mercaptopropionate in the presence of 0.75 mM hexamminechromium(III) chloride and 30 mM
potassium phosphate buffer, pH 7.0. The reference electrode is
Ag/AgCl.
[View Larger Version of this Image (14K GIF file)]
Kinetics of Cyt b5 and CYP6A1 Reduction by P450
Reductase
Purified recombinant house fly cyt
b5 was rapidly reduced in our reconstituted
system by house fly P450 reductase upon NADPH addition as shown by the
absorbance increase at 423 nm measured by stopped-flow
spectrophotometry. The reduction of cyt b5
followed apparent first-order kinetics with a rate constant of 5.5 s 1 (Fig. 9A). At least 95% of
cyt b5 was reduced by P450 reductase under these
conditions, as shown in the inset (Fig. 9A). An
increase of P450 reductase concentration did not increase the rate of
cyt b5 reduction, indicating that the rate of
5.5 s 1 is the maximal rate of cyt
b5 reduction by P450 reductase in our
reconstituted system.
CYP6A1 reduction by P450 reductase was measured at 448 nm as the CYP6A1
ferrous CO complex formation in the presence of heptachlor, a CYP6A1
substrate (Fig. 9B). Under these conditions, about 80% of
CYP6A1 was reduced by P450 reductase with an apparent first-order rate
constant of 3.0 s 1. In a separate experiment,
flash-photolysis of the preformed ferrous CO complex showed that CO
binding by the reduced CYP6A1 was completed within 10 ms. Thus, the
rate constant of 3.0 s 1 obtained in the stopped-flow
experiments represents the rate of electron transfer from P450
reductase to CYP6A1. Neither the rate nor the amount of CYP6A1 reduced
changed when the P450 reductase concentration was increased 3-fold
(data not shown), indicating that the rate of 3.0 s 1 for
CYP6A1 reduction by P450 reductase (Fig. 9B) was the maximal
rate of electron transfer in our reconstituted system.
The results of the stopped-flow experiments presented in Fig. 9
demonstrate that, under our reconstitution conditions, the three
purified recombinant proteins from the house fly interact in a
catalytically competent manner. We therefore used the reconstituted
system as a model to study the effect of cyt b5
on the catalytic turnover of CYP6A1 supported by P450 reductase.
Stimulation of CYP6A1 Turnover by Cyt b5
Prior
incubation of P450 reductase and CYP6A1 at high concentrations in the
presence of
L- -dilauroyl-sn-glycero-3-phosphocholine and
detergent was required for high rates of heptachlor epoxidation by
CYP6A1. Co-reconstitution of cyt b5 with P450
reductase and CYP6A1 resulted in a stimulation of the rate of
heptachlor epoxidation at both limiting and high P450 reductase
concentrations (Fig. 10). CYP6A1 stimulation by cyt
b5 was more prominent at lower P450 reductase
concentrations (Fig. 10, inset).
The dependence of CYP6A1 turnover on the P450 reductase concentration
in the absence and presence of 1.0 µM cyt
b5 is shown in Fig. 11. In both
cases, the heptachlor epoxidation rate increased as the concentration
of P450 reductase increased. The reaction obeyed simple hyperbolic
kinetics (Fig. 11B) and could be described by a set of
Km and Vmax values. Addition
of cyt b5 increased the
Vmax of the reaction from 24 min 1
to 57 min 1 while it decreased the Km
from 0.50 µM to 0.14 µM. Thus, cyt
b5 makes P450 reductase a more effective
electron donor in the presence of cyt b5 despite
the fact that cyt b5 drains electrons from P450
reductase.
DISCUSSION
The house fly cyt b5 is similar to
mammalian, avian, plant, and yeast cyt b5 in
that it is a protein with a hydrophobic C terminus and a highly
conserved pair of histidine residues at the core of the N-terminal heme
binding site. The noncovalently bound heme interacts with 15 amino acid
residues in the crystal structure determined for the bovine enzyme (37,
38) (marked in Fig. 1). Of these, 14 are identical or highly conserved
between the fly and the vertebrate proteins, and one (Ser-71) is
replaced by Met in the fly protein. The ``b5
fold'' described by F. S. Mathews (11) has 13 invariant residues, all
but one of which (Ala-34 in the house fly cyt
b5, Fig. 1) are exactly conserved in the fly
protein. Nonetheless, the overall amino acid positional identity of the
fly and rat microsomal protein is only 48%. A partial amino acid
sequence of the cyt b5 isolated from house fly
microsomes3 is identical to the amino acid
sequence deduced from our cDNA, thus confirming that our cDNA
in fact codes for a microsomal cyt b5.
A phylogenetic analysis not only shows that all vertebrate cyt
b5s cluster together, as was expected, but also
reveals that the vertebrate outer mitochondrial cyt
b5 is more closely related to vertebrate
microsomal cyt b5s than to fly, yeast, or plant
cyt b5s (Fig. 2). Thus, outer mitochondrial
membrane cyt b5 may have evolved from a common
microsomal cyt b5 ancestor, perhaps after the
deuterostome-protostome divergence. Our analysis also indicates that
the sequence from D. virilis, highly similar (75% identity)
to a Drosophila melanogaster cyt
b5-like sequence (52) and reported earlier to be
a cyt b5 (39), has some common features with cyt
b5 sequences including the heme binding region,
but must represent a cytochrome other than cyt
b5. These Drosophila sequences are
clearly distinct from cyt b5s and from proteins
with a cyt b5-like core such as flavocytochrome
b2, sulfite oxidase, and nitrate reductase.
Synthetic cyt b5 genes and natural cDNAs for
cyt b5 have been expressed previously in
E. coli, either constitutively (46, 53) or under the control
of lacZ (54, 55) or T7 promoter (40, 43, 56). We have
expressed the cDNA of house fly cyt b5 in
the protease deficient E. coli strain BL21, under control of
the double cassette of the strong synthetic
isopropyl- -D-thiogalactopyranoside-inducible Tac
promoter. The high expression level of up to 9 µmol/L culture enabled
us to purify the protein by a combination of conventional column
chromatography techniques with good yield (20-25%) and without the
help of an N-terminal His-tag as was done for the rat and human enzymes
(40). Upon disruption of E. coli cells by sonication, most
of the cyt b5 was found in the membrane fraction
and could be solubilized by the detergent CHAPS, suggesting the
presence of an intact C-terminal membrane-binding domain. This
suggestion is supported by our NMR studies that show relatively broad
proton resonances (Fig. 7). Because the widths of the peaks in NMR
spectra are proportional to rotational correlation time of the tumbling
species, which in turn is a function of its size (57), the broad peaks
in the house fly cyt b5 NMR spectrum (Fig. 7)
are likely to be due to cyt b5 aggregation,
possibly caused by the hydrophobic C-terminal membrane-anchoring
tail.
Although the house fly cyt b5 cDNA encodes a
protein of 15.4 kDa molecular mass, the purified protein has a
decreased electrophoretic mobility under the conditions of SDS-PAGE and
migrates as a protein of about 19 kDa (Fig. 4). A 19.7-kDa apparent
molecular mass was estimated by SDS-PAGE for the cyt
b5 purified from house fly microsomes (58).
The availability of purified house fly cyt b5
enabled us to investigate spectral and electron-transfer properties of
the protein in detail. The spectroscopic properties of house fly cyt
b5 (absorption, NMR, and EPR) indicate that this
is a typical cyt b5 protein. The g values of the
EPR spectrum of the house fly cyt b5 (Fig. 6)
are characteristic of bis-histidine-coordinated heme centers (59) in
which the histidine imidazole planes are approximately parallel in
orientation (60). Thus, the EPR spectrum indicates that the heme
binding site of house fly cyt b5 is essentially
identical, in the presentation of the protein's histidine ligands to
the metal, to those of other cyt b5s.
NMR spectroscopy is extremely sensitive to the protein environment of
the heme, the orientation of the axial ligands, and the strength of the
hydrogen bonds of the N-H protons of histidine ligands to protein
backbone residues (61). Because of the unpaired electron of the low
spin Fe(III) heme center, many of the resonances of the protons of the
heme are shifted well outside the 0-10-ppm region of the protein NMR
spectrum (38, 49, 50, 51, 61, 62). The similarity of the relative
intensities and chemical shifts of the heme resonances of recombinant
house fly cyt b5 to those of other cyt
b5s (38, 43, 47, 48), summarized in Table II, is
striking. This finding indicates that the shape of the heme pocket of
recombinant house fly cyt b5 is similar to that
of other cyt b5s. The small differences in
chemical shifts represent only very minor changes in the orientation of
the heme group with respect to the planes of the histidine ligands
(62). The NMR spectrum (Fig. 7) also reveals that heme is incorporated
into house fly cyt b5 with the two different
orientations of the heme, both forms (A and B) being present about
equally. Protein residues that line the heme binding pocket create
different shapes for the heme pockets of the cyt
b5s from various organisms. Each protein has a
different relative stability for these two forms as shown in Table II.
Thus, house fly cyt b5 is similar to both rat
cyt b5s in the lack of specificity of heme
orientation. Since the recombinant bovine microsomal (47, 53) and human
erythrocyte (48) cyt b5s, both expressed in
E. coli, each have approximately 9:1 ratios, we conclude, as
did Lloyd et al. (48), that the nearly complete
heterogeneity of heme orientation observed for two recombinant rat
proteins and house fly cyt b5 is clearly not a
result of expression in E. coli but must be due to the sizes
of the protein residues that line the heme pockets of each protein.
We have developed a modified electrode that allows rapid measurement of
the midpoint potential by cyclic voltammetry (34). Using this method
with 0.75 mM hexamminechromium(III) chloride as charge
mediator, a reduction potential of 70 mV for recombinant rat outer
mitochondrial cyt b5 was
observed,4 while the more time-consuming
spectroelectrochemical method yielded a potential of 102 mV (34).
Under the same conditions, trypsin-cleaved bovine cyt
b5 has a midpoint potential of 0 mV
versus SHE (34), very similar to its potential measured by
spectroelectrochemistry. In this work, we have measured the midpoint
potential of the house fly cyt b5 by cyclic
voltammetry and found it to be 26 mV versus SHE. These
results show that the house fly cyt b5 is more
similar in midpoint potential to the bovine microsomal protein (and
also the rat microsomal protein) (63) than it is to the rat outer
mitochondrial membrane cyt b5 (34).
The FeIII/FeII midpoint potentials of the
mammalian microsomal and erythrocyte proteins measured thus far span a
range of 9 to +5 mV (48, 64, 65, 66, 67), and those for microsomal mung bean
and yeast cyt b5s are 30 mV and 23 mV,
respectively (68, 69). Values for proteolytically cleaved cyt
b5s purified from insect tissues are 57 mV in
case of Spodoptera eridania (70) and +6 mV in case of
M. domestica (71). The wide range of reported values may
reflect different methods used to determine the midpoint potential.
Changes in overall surface charge are known to cause shifts in
reduction potential, with up to +8 to +12 mV shift in potential for
every negative charge removed (63). However, the full-length house fly
cyt b5 has a net negative charge ( 10 at
neutral pH) close to that of outer mitochondrial membrane cyt
b5 ( 9) yet the midpoint potentials for these
two proteins are significantly different ( 26 and 70 mV,
respectively, as measured by cyclic voltammetry). Thus, midpoint
potential of cyt b5s cannot be rationalized on
the basis of net charge alone, and investigations of appropriately
designed mutants using the same titration technique will be required in
order to explain the wide range of midpoint potentials of cyt
b5s.
Mammalian microsomal cyt b5s are known to be
involved in P450-dependent monooxygenase reactions (2, 3),
and studies with antibodies to house fly cyt b5
have suggested that this protein plays a similar role in insect P450
systems (28). We have demonstrated here that recombinant house fly cyt
b5 can be efficiently reduced by house fly
microsomal NADPH-dependent P450 reductase, and is able to
stimulate the activity of house fly microsomal CYP6A1 in a
reconstituted system. It is well established that two electrons are
required for a complete turnover of P450 enzymes and that
NADPH-dependent P450 reductase can provide both electrons.
It is widely held that reduced cyt b5 can serve
as an alternative donor of the second electron (12, 15, 16).
Under our experimental conditions, P450 reductase is able to provide
the first electron at a rate higher than the epoxidation rate catalyzed
by CYP6A1. Indeed, the rate constant of CYP6A1 reduction by P450
reductase is 3.0 s 1 (Fig. 9B). With 1.0 µM P450 reductase and 0.05 µM CYP6A1
present in the reaction mixture, the rate of heme reduction is 3.0 µM/s, while the rate of heptachlor epoxidation does not
exceed 0.05 µM/s even in the presence of 1.0 µM cyt b5. Moreover, total CYP6A1
turnover including both productive (heptachlor epoxidation) and
nonproductive (``uncoupled'') use of molecular oxygen occurs at much
lower rates than heme reduction.5
Therefore, CYP6A1 turnover is limited by a step following the first
electron transfer from P450 reductase. When reconstituted with 1.0 µM P450 reductase, CYP6A1 turnover increases from about
15 min 1 (without cyt b5) to about
50 min 1 with 1.0 µM cyt
b5 (Fig. 11). Because the redox potential of cyt
b5 ( 26 mV) is not negative enough to allow
efficient transfer of the first electron, and because cyt
b5 does not increase the rate of CYP6A1
reduction by P450 reductase,5 the stimulation of CYP6A1
turnover by cyt b5 (Figs. 10 and 11) appears to
be a result of an increased rate of transfer of the second
electron.
Analysis of heptachlor epoxidation as a function of P450 reductase
concentration showed that cyt b5 lowers the
apparent Km of CYP6A1 for P450 reductase 3-fold.
This novel observation can reflect: (a) different affinities
of CYP6A1 for P450 reductase in the presence and absence of cyt
b5, (b) the formation of different
P450 reductase-CYP6A1 complexes for first and second electron transfer
which are unmasked because cyt b5 changes the
rate-limiting step of epoxidation, and (c) another
unrecognized property of the reconstituted system. Experiments designed
to distinguish between these possibilities are currently under way.
FOOTNOTES
*
This work was supported in part by National Institutes of
Health Grants GM 39014 (to R. F.) and DK 31038 (to F. A. W.), and
NIEHS Center Grant ES 06694. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Entomology, Forbes 410, University of Arizona, Tucson, AZ 85721. Tel.:
520-621-9598; Fax: 520-621-1150; E-mail:
feyereisen{at}biosci.arizona.edu.
1
The abbreviations used are: cyt, cytochrome;
P450, cytochrome P450; CYP6A1, cytochrome P450 6A1; RT, reverse
transcription; PCR, polymerase chain reaction; CHAPS,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; PAGE,
polyacrylamide gel electrophoresis; SHE, standard hydrogen
electrode.
2
V. M. Guzov, J. R. Halpert, and R. Feyereisen,
unpublished observation.
3
J. G. Scott, personal communication.
4
M. Rivera, personal communication.
5
M. B. Murataliev, V. M. Guzov, and R. Feyereisen, unpublished observations.
Acknowledgments
We thank Dr. F. W. Dahlquist for a gift of
plasmid pCWori+, Dr. G. Tollin and J. Hazzard for help with
the laser flash photolysis study, Dr. J. M. C. Ribeiro for access to
the stopped-flow spectrophotometer, and M. Wheaton for recording some
of the NMR spectra.
REFERENCES
-
Sanborn, R.,
Williams, C.
(1950)
J. Gen. Physiol.
33,
579-582
[Abstract/Free Full Text]
-
Vergères, G.,
Waskell, L.
(1995)
Biochimie
77,
604-620
[Medline]
[Order article via Infotrieve]
-
Peterson, J. A.,
Prough, R. A.
(1986)
Cytochrome P450: Structure, Mechanism, and Biochemistry
(Ortiz de Montellano, P. R.,
eds)
, p. 89, Plenum Press, New York
-
Enoch, H. G.,
Strittmatter, P.
(1979)
J. Biol. Chem.
254,
8976-8981
[Free Full Text]
-
Paltauf, F.,
Prough, R. A.,
Masters, B. S. S.,
Johnson, J. M.
(1974)
J. Biol. Chem.
249,
2661-2662
[Abstract/Free Full Text]
-
Fukushima, H.,
Grinstead, G. F.,
Gaylor, J. L.
(1981)
J. Biol. Chem.
256,
4822-4826
[Abstract/Free Full Text]
-
Grinstead, G. F.,
Gaylor, J. L.
(1982)
J. Biol. Chem.
257,
13937-13944
[Free Full Text]
-
Hegesh, E.,
Hegesh, J.,
Kaftory, A.
(1986)
N. Engl. J. Med.
414,
757-761
-
Kawano, T.,
Kozutsumi, Y.,
Kawasaki, T.,
Suzuki, A.
(1994)
J. Biol. Chem.
269,
9024-9029
[Abstract/Free Full Text]
-
Ito, A.
(1980)
J. Biochem. (Tokyo)
87,
63-71
[Abstract/Free Full Text]
-
Mathews, F. S.
(1985)
Prog. Biophys. Mol. Biol.
45,
1-56
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pompon, D.,
Coon, M. J.
(1984)
J. Biol. Chem.
259,
15377-15385
[Abstract/Free Full Text]
-
Golly, I.,
Hlavica, P.,
Schartau, W.
(1988)
Arch. Biochem. Biophys.
260,
232-240
[CrossRef][Medline]
[Order article via Infotrieve]
-
Katagiri, M.,
Kagawa, N.,
Waterman, M. R.
(1995)
Arch. Biochem. Biophys.
317,
343-347
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hildebrandt, A.,
Estabrook, R. W.
(1971)
Arch. Biochem. Biophys.
143,
66-79
[CrossRef][Medline]
[Order article via Infotrieve]
-
Noshiro, M.,
Ullrich, V.,
Omura, T.
(1981)
Eur. J. Biochem.
116,
521-526
[Medline]
[Order article via Infotrieve]
-
Pompon, D.
(1987)
Biochemistry
26,
6429-6435
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gruenke, L. D.,
Konopka, K.,
Cadieu, M.,
Waskell, L.
(1995)
J. Biol. Chem.
270,
24707-24718
[Abstract/Free Full Text]
-
Shinzawa, K.,
Kominami, S.,
Takemori, S.
(1985)
Biochim. Biophys. Acta
833,
151-160
[Medline]
[Order article via Infotrieve]
-
Tamburini, P. P.,
MacFarquhar, S.,
Schenkman, J. B.
(1986)
Biochem. Biophys. Res. Commun.
134,
519-526
[CrossRef][Medline]
[Order article via Infotrieve]
-
Yamazaki, H.,
Nakano, M.,
Imai, Y.,
Ueng, Y.-F.,
Guengerich, F. P.,
Shimada, T.
(1996)
Arch. Biochem. Biophys.
325,
174-182
[CrossRef][Medline]
[Order article via Infotrieve]
-
Feyereisen, R.
(1993)
Handbook of Experimental Pharmacology, Vol. 105. Cytochrome P450
(Schenkman, J. B.,
Greim, H.,
eds)
, p. 311, Springer-Verlag, New York
-
Hodgson, E.
(1985)
Comprehensive Insect Physiology, Biochemistry and Pharmacology, Vol. 12. Insect Control
(Kerkut, G. A.,
Gilbert, L. I.,
eds)
, p. 225, Pergamon Press, New York
-
Gonzalez, F. J.,
Nebert, D. W.
(1990)
Trends Genet.
6,
182-186
[CrossRef][Medline]
[Order article via Infotrieve]
-
Feyereisen, R.,
Koener, J. F.,
Farnsworth, D. E.,
Nebert, D. W.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
1465-1469
[Abstract/Free Full Text]
-
Koener, J. F.,
Cariño, F. A.,
Feyereisen, R.
(1993)
Insect Biochem. Mol. Biol.
23,
439-447
[CrossRef][Medline]
[Order article via Infotrieve]
-
Andersen, J. F.,
Utermohlen, J. G.,
Feyereisen, R.
(1994)
Biochemistry
33,
2171-2177
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhang, M.,
Scott, J. G.
(1994)
Arch. Insect Biochem. Physiol.
27,
205-216
[CrossRef][Medline]
[Order article via Infotrieve]
-
Gish, W.,
States, D. J.
(1993)
Nat. Genet.
3,
266-272
[CrossRef][Medline]
[Order article via Infotrieve]
-
Looman, A. C.,
Bodlaender, J.,
Comstock, L. J.,
Eaton, D.,
Thurani, R.,
de Boer, H. A.,
Van Knippenberg, P. H.
(1987)
EMBO J.
6,
2489-2492
[Medline]
[Order article via Infotrieve]
-
Sambrook, J.,
Fritsch, E. F.,
Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Bauer, S.,
Shiloach, J.
(1974)
Biotechnol. Bioeng.
16,
933-941
[CrossRef][Medline]
[Order article via Infotrieve]
-
Black, S. D.,
Linger, M. H.,
Freck, L. C.,
Kazemi, S.,
Galbraith, J. A.
(1994)
Arch. Biochem. Biophys.
310,
126-133
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rivera, M.,
Wells, M. A.,
Walker, F. A.
(1994)
Biochemistry
33,
2161-2170
[CrossRef][Medline]
[Order article via Infotrieve]
-
Omura, T.,
Sato, R.
(1964)
J. Biol. Chem.
239,
2370-2378
[Free Full Text]
-
Peterson, G. L.
(1977)
Anal. Biochem.
83,
346-356
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mathews, F. S.,
Gerwinsky, E. W.,
Argos, P.
(1979)
The Porphyrins
(Dolphin, D.,
eds)
, Vol 7, p. 107, Academic Press, New York
-
Lee, K.-B.,
La Mar, G. N.,
Kehres, L. A.,
Fujinari, E. M.,
Smith, K. M.,
Pochapsky, T. C.,
Sligar, S. G.
(1990)
Biochemistry
29,
9623-9631
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kula, M. E.,
Allay, E. R.,
Rozek, C. E.
(1995)
J. Mol. Evol.
41,
430-439
[CrossRef][Medline]
[Order article via Infotrieve]
-
Holmans, P. L.,
Shet, M. S.,
Martin-Wixtrom, C. A.,
Fisher, C. W.,
Estabrook, R. W.
(1994)
Arch. Biochem. Biophys.
312,
554-565
[CrossRef][Medline]
[Order article via Infotrieve]
-
Strittmatter, P.,
Velick, S. F.
(1956)
J. Biol. Chem.
221,
253-264
[Free Full Text]
-
Spatz, L.,
Strittmatter, P.
(1971)
Proc. Natl. Acad. Sci. U. S. A.
68,
1042-1046
[Abstract/Free Full Text]
-
Rivera, M.,
Barillas-Mury, C.,
Christensen, K. A.,
Little, J. W.,
Wells, M. A.,
Walker, F. A.
(1992)
Biochemistry
31,
12233-12240
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bois-Poltoratsky, R.,
Ehrenberg, A.
(1967)
Eur. J. Biochem.
2,
361-365
[Medline]
[Order article via Infotrieve]
-
Passon, P. G.,
Reed, D. W.,
Hultquist, D. E.
(1972)
Biochim. Biophys. Acta
275,
51-61
[Medline]
[Order article via Infotrieve]
-
Von Bodman, S. B.,
Schuler, M. A.,
Jollie, D. R.,
Sligar, S. G.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
9443-9447
[Abstract/Free Full Text]
-
Burch, A. M.,
Rigby, S. E. J.,
Funk, W. D.,
MacGillivray, R. T. A.,
Mauk, M. R.,
Mauk, A. G.,
Moore, G. R.
(1990)
Science
247,
831-833
[Abstract/Free Full Text]
-
Lloyd, E.,
Ferrer, J. C.,
Funk, W. D.,
Mauk, M. M.,
Mauk, A. G.
(1994)
Biochemistry
33,
11432-11437
[CrossRef][Medline]
[Order article via Infotrieve]
-
Keller, R. M.,
Wüthrich, K.
(1972)
Biochim. Biophys. Acta
285,
326-336
[Medline]
[Order article via Infotrieve]
-
Keller, R. M.,
Wüthrich, K.
(1980)
Biochim. Biophys. Acta
621,
204-217
[Medline]
[Order article via Infotrieve]
-
La Mar, G. N.,
Burns, P. D.,
Jackson, J. T.,
Smith, K. M.,
Langry, K. C.,
Strittmatter, P.
(1981)
J. Biol. Chem.
256,
6075-6079
[Free Full Text]
-
Levin, R. J.,
Boychuk, P. L.,
Croniger, C. M.,
Kazzaz, J. A.,
Rozek, C. E.
(1989)
Nucleic Acids Res.
13,
631-644
[Abstract/Free Full Text]
-
Funk, W. D.,
Lo, T. P.,
Mauk, M. R.,
Brayer, G. D.,
MacGillivray, R. T. A.,
Mauk, A. G.
(1990)
Biochemistry
29,
5500-5508
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ladokhin, A. S.,
Wang, L.,
Steggles, A. W.,
Holloway, P. W.
(1991)
Biochemistry
30,
10200-10206
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hewson, R.,
Newbold, R. J.,
Whitford, D.
(1993)
Protein Eng.
6,
953-964
[Abstract/Free Full Text]
-
Smith, M. A.,
Napier, J. A.,
Stymne, S.,
Tatham, A. S.,
Shewry, P. R.,
Stobart, A. K.
(1994)
Biochem. J.
303,
73-79
-
Sanders, J. K. M., and Hunter, B. K. (1993) Modern NMR
Spectroscopy: A Guide for Chemists, 2nd Ed., pp. 163 and 214, Oxford University Press, New York
-
Wheelock, G. D.,
Scott, J. G.
(1989)
Insect Biochem.
19,
481-488
[CrossRef]
-
Peisach, J.,
Blumberg, W. E.,
Adler, A. D.
(1973)
Ann. N. Y. Acad. Sci.
206,
310-327
[Medline]
[Order article via Infotrieve]
-
Walker, F. A.,
Huynh, B. H.,
Scheidt, W. R.,
Osvath, S. R.
(1986)
J. Am. Chem. Soc.
108,
5288-5297
[CrossRef]
-
Satterlee, J. D.
(1987)
Metal Ions Biol. Syst.
21,
121-185
-
McLachlan, S. J.,
La Mar, G. N.,
Lee, K. B.
(1988)
Biochim. Biophys. Acta
957,
430-445
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rodgers, K. K.,
Sligar, S. G.
(1991)
J. Am. Chem. Soc.
113,
9419-9432
[CrossRef]
-
Lee, K.-B.,
Jun, E.,
La Mar, G. N.,
Rezzano, I. N.,
Pandey, R. K.,
Smith, K. M.,
Walker, F. A.,
Buttlaire, D. H.
(1991)
J. Am. Chem. Soc.
113,
3576-3583
[CrossRef]
-
Reid, L. S.,
Mauk, A. G.
(1982)
J. Am. Chem. Soc.
104,
841-845
[CrossRef]
-
Reid, L. S.,
Taniguchi, V. T.,
Gray, H. B.,
Mauk, A. G.
(1982)
J. Am. Chem. Soc.
104,
7516-7519
[CrossRef]
-
Walker, F. A.,
Emrick, D.,
Rivera, J. E.,
Hanquet, B. J.,
Buttlaire, D. H.
(1988)
J. Am. Chem. Soc.
110,
6234-6240
[CrossRef]
-
Shichi, H.,
Hackett, D. P.
(1962)
J. Biol. Chem.
237,
2959-2964
[Free Full Text]
-
Yoshida, Y.,
Kumaoka, H.,
Sato, R.
(1974)
J. Biochem.
75,
1211-1219
[Abstract/Free Full Text]
-
McFadden, K. A.,
Crankshaw, D. L.,
Hetnarski, H. K.,
Wilkinson, C. F.
(1979)
Insect Biochem.
9,
301-308
[CrossRef]
-
Okada, Y.,
Okunuki, K.
(1969)
J. Biochem. (Tokyo)
65,
581-596
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Wang, A. B. Cowley, and D. R. Benson
Enhancing the thermal stability of mitochondrial cytochrome b5 by introducing a structural motif characteristic of the less stable microsomal isoform
Protein Eng. Des. Sel.,
October 24, 2007;
(2007)
gzm053v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Nakanishi, F. Takeuchi, H. Okamoto, A. Tamura, H. Hori, and M. Tsubaki
Characterization of Heme-Coordinating Histidyl Residues of Cytochrome b5 Based on the Reactivity with Diethylpyrocarbonate: A Mechanism for the Opening of Axial Imidazole Rings
J. Biochem.,
October 1, 2006;
140(4):
561 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sun, A. Wang, A. B. Cowley, A. Altuve, M. Rivera, and D. R. Benson
Enhancing the stability of microsomal cytochrome b5: a rational approach informed by comparative studies with the outer mitochondrial membrane isoform
Protein Eng. Des. Sel.,
December 1, 2005;
18(12):
571 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Sutherland, G. C. Unnithan, J. F. Andersen, P. H. Evans, M. B. Murataliev, L. Z. Szabo, E. A. Mash, W. S. Bowers, and R. Feyereisen
A cytochrome P450 terpenoid hydroxylase linked to the suppression of insect juvenile hormone synthesis
PNAS,
October 27, 1998;
95(22):
12884 - 12889.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|